Technology
Health
Pharmaceutical

Gamida Cel

$3.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.25 (8.33%) As of 2:57 PM EDT today
+$0.25 (8.33%) Today

Why Robinhood?

You can buy or sell Gamida Cel and other stocks, options, ETFs, and crypto commission-free!

About GMDA

Gamida Cell Ltd. Ordinary Shares, also called Gamida Cel, is a clinical stage biopharmaceutical company, which engages in the development of cell therapies that are designed to cure blood cancer and rare serious hematologic diseases. Read More The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel.

Employees
73
Headquarters
Jerusalem, Jerusalem
Founded
1998
Market Cap
75.39M
Price-Earnings Ratio
Dividend Yield
Average Volume
20.95K
High Today
$3.25
Low Today
$3.05
Open Price
$3.05
Volume
31.46K
52 Week High
$15.41
52 Week Low
$2.93

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
Cancer Prevention
2018 IPO
Asia (Non-China)

GMDA News

Benzinga9h

Stem Cell & Regenerative Therapy Markets to 2024 Featuring Aldagen, Caladrius Biosciences, Daiichi Sankyo Co, Gamida Cell, Novartis, and More

0

GMDA Earnings

-$32.79
-$21.98
-$11.18
-$0.37
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.45 per share
Actual
-$0.44 per share

More GMDA News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.